CLDN18.2-positive Advanced Biliary Tract Cancer
1 clinical trials · Condition
◉ Watch CLDN18.2-positive Advanced Biliary Tract Cancer
| Record | Firm | Date |
|---|---|---|
| Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer (NCT07151872) | Qilu Pharmaceutical Co., Ltd. | 2025-09-01 |
Track CLDN18.2-positive Advanced Biliary Tract Cancer automatically
Every clearance here is in the API, with alerts when new ones post.